Suk‐Kyun Yang

14.4k total citations · 1 hit paper
384 papers, 9.5k citations indexed

About

Suk‐Kyun Yang is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Suk‐Kyun Yang has authored 384 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Genetics, 176 papers in Surgery and 148 papers in Epidemiology. Recurrent topics in Suk‐Kyun Yang's work include Inflammatory Bowel Disease (178 papers), Microscopic Colitis (92 papers) and Gastric Cancer Management and Outcomes (60 papers). Suk‐Kyun Yang is often cited by papers focused on Inflammatory Bowel Disease (178 papers), Microscopic Colitis (92 papers) and Gastric Cancer Management and Outcomes (60 papers). Suk‐Kyun Yang collaborates with scholars based in South Korea, United States and Singapore. Suk‐Kyun Yang's co-authors include Byong Duk Ye, Seung‐Jae Myung, Sang Hyoung Park, Jeong‐Sik Byeon, Dong‐Hoon Yang, Edward V. Loftus, William J. Sandborn, Kyung‐Jo Kim, Hyun Kwon Ha and Seong Ho Park and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Suk‐Kyun Yang

368 papers receiving 9.3k citations

Hit Papers

A common missense variant in NUDT15 confers susceptibilit... 2014 2026 2018 2022 2014 100 200 300

Peers

Suk‐Kyun Yang
Byong Duk Ye South Korea
Bret A. Lashner United States
Jae Hee Cheon South Korea
Karel Geboes Belgium
David B. Sachar United States
Cyriel Y. Ponsioen Netherlands
Byong Duk Ye South Korea
Suk‐Kyun Yang
Citations per year, relative to Suk‐Kyun Yang Suk‐Kyun Yang (= 1×) peers Byong Duk Ye

Countries citing papers authored by Suk‐Kyun Yang

Since Specialization
Citations

This map shows the geographic impact of Suk‐Kyun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suk‐Kyun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suk‐Kyun Yang more than expected).

Fields of papers citing papers by Suk‐Kyun Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suk‐Kyun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suk‐Kyun Yang. The network helps show where Suk‐Kyun Yang may publish in the future.

Co-authorship network of co-authors of Suk‐Kyun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Suk‐Kyun Yang. A scholar is included among the top collaborators of Suk‐Kyun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suk‐Kyun Yang. Suk‐Kyun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ying, et al.. (2025). Decoding the neuroimmune axis in colorectal cancer: From neural circuitry to therapeutic innovation. Cytokine & Growth Factor Reviews. 83. 3–17. 2 indexed citations
2.
Kim, Hae Won, et al.. (2024). Effects of a Pre-Conception Care Program in Women with Inflammatory Bowel Disease: A Mixed-Methods Study Including a Randomized Controlled Trial. Journal of Korean Academy of Nursing. 54(3). 386–386. 2 indexed citations
3.
Kim, Seon‐Ok, Sung Wook Hwang, Sang Hyoung Park, et al.. (2024). Continuing or stopping 5‐aminosalicylates in patients with inflammatory bowel disease on anti‐TNF therapy: A nationwide population‐based study. Alimentary Pharmacology & Therapeutics. 60(3). 389–400. 2 indexed citations
4.
Park, Su Hyun, Seung Wook Hong, Sang Hyoung Park, et al.. (2024). Fecal Calprotectin in Patients with Crohn’s Disease: A Study Based on the History of Bowel Resection and Location of Disease. Diagnostics. 14(8). 854–854. 2 indexed citations
5.
Hong, Seung Wook, Sang Hyoung Park, Dong‐Hoon Yang, et al.. (2024). Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure. Gut and Liver. 18(4). 667–676. 5 indexed citations
6.
Hong, Seung Wook, Sung Wook Hwang, Jong Lyul Lee, et al.. (2024). Incidence, Risk Factors, and Outcomes of Chronic Antibiotic-Refractory Pouchitis in Korean Patients with Ulcerative Colitis. Gut and Liver. 19(3). 388–397.
7.
Kim, Kyuwon, Seung Wook Hong, Sung Wook Hwang, et al.. (2024). Safety of Biologics and Small Molecules for Inflammatory Bowel Diseases in Organ Transplant Recipients. Yonsei Medical Journal. 65(5). 276–276. 2 indexed citations
8.
Park, Seong Ho, et al.. (2023). A Novel Chronic Enteropathy Associated with SLCO2A1 Gene Mutation: Enterography Findings in a Multicenter Korean Registry. Korean Journal of Radiology. 24(4). 305–305. 4 indexed citations
9.
Lee, Jung-Bok, Sang Hyoung Park, Suk‐Kyun Yang, et al.. (2022). Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study. Intestinal Research. 21(1). 137–147. 4 indexed citations
10.
Ye, Byong Duk, et al.. (2022). The Risk of Tuberculosis in Patients With Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab in Korea. Journal of Korean Medical Science. 37(14). e107–e107. 14 indexed citations
11.
Choi, Kee Don, Hyeong Ryul Kim, Tae Sun Shim, et al.. (2021). Bronchoesophageal fistula in a patient with Crohn’s disease receiving anti-tumor necrosis factor therapy. Clinical Endoscopy. 56(2). 239–244. 1 indexed citations
12.
Oh, Eun Hye, Jeongseok Kim, Sung Wook Hwang, et al.. (2020). Factors Associated with Clinical Outcomes of Palliative Stenting for Malignant Colonic Obstruction. Gut and Liver. 15(4). 579–587. 5 indexed citations
13.
Jung, Sung-Ae, Sang Hyoung Park, Chang Mo Moon, et al.. (2019). Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children’s immunity. Intestinal Research. 17(2). 237–243. 24 indexed citations
14.
Yang, Dong‐Hoon, Sneha John, Mitsuhiro Fujishiro, et al.. (2019). Endoscopic Diagnosis of Nonpedunculated Dysplasia during Surveillance of Ulcerative Colitis: A Survey-Based Multinational Study. Gut and Liver. 14(5). 611–618. 5 indexed citations
15.
Kang, Jieun, Minkyu Han, Suk‐Kyun Yang, et al.. (2018). Incidence of Active Tuberculosis within One Year after Tumor Necrosis Factor Inhibitor Treatment according to Latent Tuberculosis Infection Status in Patients with Inflammatory Bowel Disease. Journal of Korean Medical Science. 33(47). e292–e292. 12 indexed citations
16.
Oh, Eun Hye, Dae‐Hyun Ko, Gwang‐Un Kim, et al.. (2017). Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease. World Journal of Gastroenterology. 23(8). 1489–1489. 8 indexed citations
17.
Myung, Jae, Dong Il Park, Sang Hyoung Park, et al.. (2016). Physicians Should Provide Shared Decision-Making for Anti-TNF Therapy to Inflammatory Bowel Disease Patients. Journal of Korean Medical Science. 32(1). 85–85. 8 indexed citations
18.
Myung, Seung‐Jae, Young Soo Park, Dong‐Hoon Yang, et al.. (2013). Inhibition of 15-Hydroxyprostaglandin Dehydrogenase by Helicobacter pylori in Human Gastric Carcinogenesis. Cancer Prevention Research. 6(4). 349–359. 11 indexed citations
19.
Byeon, Jeong‐Sik, Seong Ho Park, Dong‐Hoon Yang, et al.. (2010). Clinical characteristics of spontaneous intestinal intramural hematoma: a single-center experience. The Korean Journal of Internal Medicine. 79(5). 518–525.
20.
Bang, Sung‐Jo, Jeong‐Sik Byeon, Hyun‐Jun Kim, et al.. (2004). Two Cases of Intussusception Occurring through the Stoma after Gastric Surgery. Clinical Endoscopy. 28(4). 183–187. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026